These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 35711437)

  • 61. Classification of molecular subtypes for colorectal cancer and development of a prognostic model based on necroptosis-related genes.
    Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
    Heliyon; 2024 Mar; 10(5):e26781. PubMed ID: 38439879
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 63. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma.
    Tang Y; Guo C; Yang Z; Wang Y; Zhang Y; Wang D
    Front Immunol; 2022; 13():862527. PubMed ID: 35493471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer.
    Liu C; Lu Z; Yan J; Xue D; He X; Huang W; Sun Q; Zhao W; Li F
    Front Oncol; 2023; 13():1234045. PubMed ID: 37564935
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer.
    Qiu P; Chen X; Xiao C; Zhang M; Wang H; Wang C; Li D; Liu J; Chen Y; Liu L; Zhao Q
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6411-6434. PubMed ID: 36757621
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
    Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
    Front Immunol; 2022; 13():984480. PubMed ID: 36389763
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancer.
    Li Q; Liu G; Qiu Q; Zhang J; Li R; Zhao J; She J; Chen Y
    Sci Rep; 2024 Jan; 14(1):2180. PubMed ID: 38273073
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Coagulation- and fibrinolysis-related genes for predicting survival and immunotherapy efficacy in colorectal cancer.
    Ma Y; Wang B; He P; Qi W; Xiang L; Maswikiti EP; Chen H
    Front Immunol; 2022; 13():1023908. PubMed ID: 36532065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer.
    Wang X; Xu Y; Dai L; Yu Z; Wang M; Chan S; Sun R; Han Q; Chen J; Zuo X; Wang Z; Hu X; Yang Y; Zhao H; Hu K; Zhang H; Chen W
    Front Immunol; 2022; 13():1043738. PubMed ID: 36389694
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
    Li X; Xie M; Yin S; Xiong Z; Mao C; Zhang F; Chen H; Jin L; Lan P; Lian L
    Front Genet; 2021; 12():666003. PubMed ID: 34017356
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature.
    Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX
    BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A novel 10-gene immune-related lncRNA signature model for the prognosis of colorectal cancer.
    Ma B; Cao L; Li Y
    Math Biosci Eng; 2021 Nov; 18(6):9743-9760. PubMed ID: 34814366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
    Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
    Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
    Chen G; Dong Z; Wu D; Chen Y
    J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.